Abstract:The transition elements (groups IIIB to IIB)-based materials present advantageous morphological and physicochemical attributes due to the exceptionally variable valence states and highly stable metal ions. Among the first-row transition elements-based materials, manganese dioxide (MnO2) has garnered enormous interest from researchers due to the ease of fabricating diverse nanostructures in multiple dimensions (0-3D) with unique physicochemical, morphological, and optoelectronic characteristics. In addition to their excellent carrying ability as vectors, MnO2-based nanoarchitectures present several features of participating in the intracellular biochemical reactions and altering the internal tumor microenvironment. To preserve these exceptional features and improve biocompatibility, several MnO2-based architectures and nanocomposites have been fabricated. In this article, we provide a comprehensive view of various MnO2-based nanoplatforms in different forms, such as 0D (nanodots), 1D (nanowires and nanotubes), 2D (nanosheets), and 3D (nanoparticles and hollow spheres), as well as various innovative constructs (Janus-type and flower-shaped architectures). Initially, we provide insights on different engineering strategies, highlighting the pros and cons focusing on the reaction conditions. Further, we give a detailed exploration of these nanostructures and the offered properties that play crucial roles in their applicability. Then, we provide an emphasis on their applicability in diverse biomedical applications, such as conventional (drugs/photosensitizers/proteins/genes) and innovative therapeutic (chemodynamic, photodynamic, sonodynamic, and photothermal) modalities, bioimaging, biosensing, biocatalysis, cell capture/enrichment, as well as tissue regeneration. Finally, we summarize with interesting perspectives in addressing the challenges of translating these innovative platforms to clinics.

An Overview of Recent Advancements on Manganese-Based Nanostructures and Their Application for ROS-Mediated Tumor Therapy

Targeted Gsh-Exhausting And Hydroxyl Radical Self-Producing Manganese-Silica Nanomissiles For Mri Guided Ferroptotic Cancer Therapy

Manganese Dioxide (mno2) Based Nanomaterials for Cancer Therapies and Theranostics

Therapeutic application of manganese-based nanosystems in cancer radiotherapy

Cancer diagnosis and treatment platform based on manganese-based nanomaterials

Manganese‐based tumor immunotherapy

Manganese-derived biomaterials for tumor diagnosis and therapy

Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Current advances in metal–organic frameworks for cancer nanodynamic therapies

Advances in the Biological Mechanism and Application of Manganese-Based Nanoformulations for Enhanced Immunotherapy

Manganese-induced Photothermal-Ferroptosis for Synergistic Tumor Therapy

Microorganism-enabled Photosynthetic Oxygeneration and Ferroptosis Induction Reshape Tumor Microenvironment for Augmented Nanodynamic Therapy.

Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn2+/Mn4+ and Mo5+/Mo6+) for Augmented Cancer Theranostics

Nanoarchitectured manganese dioxide (MnO2)-based assemblies for biomedicine

Manganese‐Based Nanozymes: Preparation, Catalytic Mechanisms, and Biomedical Applications

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Biomedical applications of MnO2 nanomaterials as nanozyme-based theranostics

MXene‐Mediated Catalytic Redox Reactions for Biomedical Applications

Structure-property Relationships in Manganese Oxide - Mesoporous Silica Nanoparticles Used for T1-weighted MRI and Simultaneous Anti-Cancer Drug Delivery

Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy.